Affiliation:
1. Ardabil University of Medical Sciences
Abstract
Abstract
Background
One of the emotional problems in patients experiencing cancer is demoralization syndrome. Concerning the importance of demoralization in cancer patients, having a valid and reliable scale for assessing this problem is crucial. A revised version of Demoralization Scale (DS-II) has been designed in 2016. It was necessary to determine its validity and reliability in population with different culture. This study aimed to determine the psychometric properties of the Persian version of DS-II (PDS-II) in Iranian cancer patients.
Methods
The study population comprised 170 Iranian cancer patients in Ardabil, Iran. To determine the psychometric properties of PDS-II, the content, convergent, construct, and discriminant validity, besides internal consistency, were evaluated.
Results
Regarding the high correlation of PDS-II with GAD-7, PHQ-9, BHS, and HADS, the convergent validity of the PDS-II was confirmed. Confirmatory factor analyses confirmed both the original 2-factor and one-factor models of PDS-II. Internal discriminant validity of the PDS-II was not confirmed because the Average Variance Extracted from two dimensions of PDS-II (AVE = 0.31 and 0.37) was less than the square correlation between these two dimensions (r2 = 0.79). As the patients with a low Karnofsky score acquired more demoralization (p < 0.0001), the external discriminant validity of PDS-II was confirmed. Cronbach α coefficient was 0.88 for the PDS-II.
Conclusions
PDS-II is a valid and reliable scale for measuring demoralization among Iranian people with cancer. However, there is a high overlap between the two dimensions of PDS-II.
Publisher
Research Square Platform LLC
Reference36 articles.
1. Cancer statistics for the year 2020: An overview;Ferlay J;Intern J Cancer,2021
2. Cancer incidence in Iran in 2014: results of the Iranian National Population-based Cancer Registry;Roshandel G;Cancer Epidemiol,2019
3. Physical and mental health among cancer survivors: considerations for long-term care and quality of life;Naughton MJ;N C Méd J,2014
4. History of psycho-oncology: overcoming attitudinal and conceptual barriers;Holland JC;Psychosom Med,2002
5. The measure of distress;Larouche S;Oncol Exch,2004